Sign in
8-K

Current Report

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-19-262065

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading d815726d8k.htm…